Osteoporosis treatment for men typically starts with bisphosphonates like alendronate or zoledronic acid, combined with calcium, vitamin D, and weight-bearing exercise. But here’s what most men don’t realize: roughly 1 in 4 men over age 50 will break a bone due to osteoporosis, and men who fracture a hip are actually twice as likely to die within a year compared to women with the same injury. This isn’t a women’s disease — it’s an underdiagnosed crisis in men.
The reason osteoporosis treatment for men matters so much is the diagnostic gap. Men get screened far less frequently, get diagnosed later, and start treatment at more advanced stages of bone loss. Understanding the condition and exploring management strategies early — ideally before the first fracture — can be the difference between independence and disability in later life.
Why Do Men Get Osteoporosis?
Men build larger, denser bones than women and don’t experience the sharp hormonal cliff of menopause. But starting around age 65–70, bone loss accelerates significantly. About 20% of all osteoporosis cases in the U.S. occur in men, and roughly 2 million American men currently have the condition — with another 12 million at risk.
Secondary osteoporosis (caused by another medical condition or medication) accounts for up to 50–60% of cases in men, compared to only about 20–30% in women. This distinction is critical because it means there’s often a treatable underlying cause.
Top Risk Factors in Men
| Risk Factor | Category | Why It Matters |
|---|---|---|
| Glucocorticoid use (≥5 mg prednisone daily for ≥3 months) | Medication | Most common cause of secondary osteoporosis in men |
| Hypogonadism / low testosterone | Hormonal | Testosterone is converted to estradiol, which protects bone |
| Androgen deprivation therapy (prostate cancer) | Medication | Can cause 3–5% bone loss per year |
| Excessive alcohol (≥3 drinks/day) | Lifestyle | Directly toxic to osteoblasts (bone-building cells) |
| Smoking | Lifestyle | Reduces bone density by ~2% for every 10 pack-years |
| Age >70 | Non-modifiable | Age-related bone loss accelerates in the 7th decade |
| Low body weight (BMI <20) | Body composition | Less mechanical loading on bones |
| Family history of hip fracture | Genetic | Heritable component accounts for 50–80% of bone density variation |
How Osteoporosis Is Diagnosed in Men
The gold standard is a DEXA scan (dual-energy X-ray absorptiometry), which measures bone mineral density at the hip and lumbar spine. The results come back as a T-score:
- T-score ≥ -1.0: Normal bone density
- T-score -1.0 to -2.5: Osteopenia (low bone mass)
- T-score ≤ -2.5: Osteoporosis
The Endocrine Society recommends screening men at age 70, or at age 50–69 if they have risk factors like glucocorticoid use, low testosterone, prior fragility fracture, or a history of falls. Despite this, fewer than 10% of men with osteoporosis get diagnosed before their first fracture.
Your doctor should also check serum 25-hydroxyvitamin D, calcium, testosterone, thyroid function, and a complete metabolic panel to rule out secondary causes. A FRAX score — a 10-year fracture risk calculator — helps guide treatment decisions, especially in men with osteopenia.
6 Proven Osteoporosis Treatments for Men
1. Bisphosphonates (First-Line)
Alendronate (70 mg weekly) and zoledronic acid (5 mg IV once yearly) are FDA-approved for men and reduce vertebral fracture risk by 40–70%. Risedronate is another oral option. These drugs work by slowing down osteoclasts — the cells that break down bone.
2. Denosumab (Prolia)
A subcutaneous injection given every 6 months, denosumab is FDA-approved for men at high fracture risk and for men on androgen deprivation therapy for prostate cancer. It reduced new vertebral fractures by 62% in clinical trials. One caution: stopping denosumab abruptly can cause rapid rebound bone loss and multiple vertebral fractures.
3. Teriparatide (Forteo)
An anabolic agent — meaning it actually builds new bone rather than just slowing breakdown. Teriparatide is a synthetic parathyroid hormone given as a daily subcutaneous injection for up to 2 years. It’s typically reserved for men with severe osteoporosis or those who fracture despite bisphosphonate therapy.
4. Abaloparatide (Tymlos)
Another bone-building agent similar to teriparatide, abaloparatide reduced vertebral fracture risk by 86% in the ACTIVE trial. It’s a daily injection limited to a 2-year treatment course, followed by an antiresorptive agent to maintain gains.
5. Romosozumab (Evenity)
The newest option — a sclerostin inhibitor that both builds bone and reduces resorption simultaneously. Given as monthly injections for 12 months, romosozumab increased spine bone density by approximately 13% in men. It carries a cardiovascular warning and isn’t appropriate for men with recent heart attack or stroke.
6. Testosterone Replacement Therapy
For men with confirmed hypogonadism (total testosterone consistently below 300 ng/dL), testosterone replacement can improve bone density. However, testosterone alone is rarely sufficient as a standalone osteoporosis treatment — most guidelines recommend adding a bone-specific agent if the T-score is ≤ -2.5 or if fractures have occurred.
Non-Drug Strategies That Actually Help
- Calcium: 1,000–1,200 mg daily (food sources preferred over supplements)
- Vitamin D: 800–1,000 IU daily; target serum 25(OH)D level of 30–50 ng/mL
- Weight-bearing exercise: 30 minutes most days — walking, jogging, stair climbing, resistance training
- Fall prevention: Balance training, home safety modifications, medication review (especially sedatives)
- Quit smoking and limit alcohol to ≤2 drinks per day
- Protein intake: Aim for 1.0–1.2 g/kg body weight daily to support muscle and bone
When to See a Doctor
Don’t wait for a fracture. See your doctor for bone density evaluation if you:
- Are a man over 70 (regardless of risk factors)
- Are 50–69 with any risk factor listed above
- Have lost more than 1.5 inches (4 cm) of height
- Have broken a bone from a minor fall or impact after age 50
- Take prednisone or similar steroids for more than 3 months
- Are on androgen deprivation therapy for prostate cancer
Ask specifically: “Should I get a DEXA scan?” Many primary care physicians simply don’t think to screen men — you may need to advocate for yourself.
Frequently Asked Questions
At what age should men be screened for osteoporosis?
The standard recommendation is age 70 for all men. However, men aged 50–69 should be screened earlier if they have risk factors such as glucocorticoid use, low testosterone, prior fragility fracture, excessive alcohol use, or family history of osteoporosis. Men on androgen deprivation therapy for prostate cancer should get a baseline DEXA before or shortly after starting treatment.
Can men reverse osteoporosis, or only slow it down?
Anabolic therapies like teriparatide, abaloparatide, and romosozumab can genuinely rebuild bone — not just slow loss. In clinical trials, romosozumab increased lumbar spine bone density by 13% in 12 months. After the anabolic phase, switching to a bisphosphonate or denosumab helps lock in those gains. “Reversal” depends on severity, but meaningful improvement in bone density is absolutely achievable.
Is osteoporosis more dangerous in men than women?
Fracture-for-fracture, yes. Men who sustain a hip fracture have a 1-year mortality rate of approximately 30–37%, compared to about 20% in women. Men tend to be older at diagnosis, have more comorbidities, and receive less post-fracture treatment. Only about 10% of men receive osteoporosis medication after a hip fracture, compared to roughly 20–30% of women — both numbers are unacceptably low.
Does low testosterone always cause osteoporosis?
No, but it’s a significant risk factor. Testosterone is partly converted to estradiol in men, and estradiol actually plays a larger role in maintaining male bone density than testosterone itself. Men with consistently low testosterone (below 300 ng/dL) should have a DEXA scan, but many men with normal testosterone still develop osteoporosis from other causes like aging, medications, or vitamin D deficiency.
How long do men need to take osteoporosis medication?
Bisphosphonates are typically prescribed for 3–5 years, then reassessed. Anabolic agents (teriparatide, abaloparatide) are limited to 2 years and must be followed by an antiresorptive drug. Denosumab requires ongoing treatment because stopping it leads to rapid bone loss. Your doctor should re-evaluate fracture risk periodically with repeat DEXA scans and FRAX scoring to determine whether to continue, switch, or pause therapy.
